NCT06889545 Comparison of Preoperative Frailty Assessment Tools
| NCT ID | NCT06889545 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | Frailty |
| Study Type | OBSERVATIONAL |
| Enrollment | 584 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2027-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 584 participants in total. It began in 2025-04-15 with a primary completion date of 2027-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Frailty is a significant risk factor for postoperative complications and functional decline. Preoperative assessment of frailty is therefore recommended in all older adults. However, despite the availability of many frailty tools, few have been tested in the preoperative setting and there is little comparison of their predictive value in identifying patients at risk. The aim of this study is to investigate which of the following instruments for determining frailty has the highest predictive power with regard to the occurrence of postoperative complications: Risk Analysis Index, Clinical Frailty Scale, the Groningen Frailty Indicator, the Edmonton Frail Scale and the LUCAS-FI. The aim of this research project is to identify a suitable frailty instrument for preoperative risk stratification of older patients during the premedication visit.
Eligibility Criteria
Inclusion Criteria: * 70 years and older * scheduled surgery * estimated time of surgery 120 Minutes or more Exclusion Criteria: * insufficient German language skills (for cognitive testing) * mental retardation * relevant psychiatric disorder (not allowing for cognitive testing)
Contact & Investigator
Dr. Cynthia Olotu, MD
PRINCIPAL INVESTIGATOR
University Medical Centre Hamburg
Frequently Asked Questions
Who can join the NCT06889545 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06889545 currently recruiting?
Yes, NCT06889545 is actively recruiting participants. Contact the research team at c.olotu@uke.de for enrollment information.
Where is the NCT06889545 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT06889545 clinical trial?
NCT06889545 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The principal investigator is Dr. Cynthia Olotu, MD at University Medical Centre Hamburg. The trial plans to enroll 584 participants.